Differentiation of osteblasts and osteocytes from mesenchymal stem cells

Current Stem Cell Research and Therapy

Volumn 3, Issue 2, 2008, Pages 131-145

  Heino, Terhi J ^a   Hentunen, Teuvo A ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bone metabolism; Mesenchymal stem cells; Osteoblasts; Osteocytes; Tissue engineering

Indexed keywords

FIBROBLAST GROWTH FACTOR; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADIPOCYTE; ANGIOGENESIS; BONE DEFECT; BONE MARROW BIOPSY; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL THERAPY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; ANIMAL; BONE; CYTOLOGY; VASCULARIZATION;

ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOCYTES; TISSUE ENGINEERING;

EID: 47749102180     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488808784223032     Document Type: Review

References (172)

1. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5(3): 309-13.
2. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001; 344(5): 385-6.
3. Becker AJ, Mc Culloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963; 197: 452-4.
4. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4(5): 267-74.
5. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988; 136: 42-60.
6. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641-50.
7. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2(6): 477-88.
8. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21(1): 105-10.
9. Igura K, Zhang Y, Takahashi K, et al. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004; 6(6): 543-53.
10. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
11. Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98(8): 2396-402.
12. Dazzi F, Ramasamy R, Glennoie S, et al. The role of mesenchymal stem cells in haemopoiesis. Blood Rev 2006; 20(3): 161-71.
13. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal. cells. Cytotherapy 2001; 3(5): 393-6.
14. Tropel P, Noel D, Platet N, et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2004; 295(2): 395-406.
15. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181(1):67-73.
16. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978; 4(1-2): 7-25.
17. Nilsson SK, Dooner MS, Tiarks CY, et al. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood 1997; 89(11): 4013-20.
18. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 200 1; 97(8): 2293-9.
19. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425(6960): 836-41.
20. Kiel MJ, Yilmaz OH, Iwashita T, et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005; 121(7): 1109-21.
21. Bhardwaj G, Murdoch B, Wu D, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2(2): 172-80.
22. Willert K, Brown JD, Denenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003; 423(6938):448-52.
23. Karanu FN, Murdoch B, Gallacher L, et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192(9): 1365-72.
24. Varnum-Finney B, Purton LE, Yu M, et al. Tbe Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood t998; 91(11): 4084-91.
25. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425(6960): 841-6.
26. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004; 118(2): 149-61.
27. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005; 201(11): 1781-91.
28. Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006; 12(6): 657-64.
29. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006; 14(8): 967-75.
30. Van Overstraeten-Schlogel N, Beguin Y, Gothot A. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol 2006; 76(6): 488-93.
31. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2(4): 389-406.
32. Schroeder TM, Jensen ED, Westendorf JJ. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today 2005; 75(3): 213-25.
33. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89(5): 755-64.
34. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89(5): 765-71.
35. Franceschi RT, Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 2003; 88(3): 446-54.
36. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89(5): 747-54.
37. Isenmann S, Cakouros D, Zannettino A, et al. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations. J Bone Miner Res 2007; 22(6):897-906.
38. Akiyama H, Kim JE, Nakashima K, et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Nad Acad Sci USA 2005; 102(41): 14665-70.
39. Zhou G, Zheng Q, Engin F, et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 2006; 103(50):19004-9.
40. Nakashima Y, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
41. Park SR, Oreffo RO, Triffift JT. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 1999; 24(6): 549-54.
42. Schiller PC, D'Ippolito G, Brambilla R, et al. Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J Biol Chem 2001; 276(17):14133-8.
43. Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 2004; 18(9):980-2.
44. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004; 4(3): 290-4.
45. Hong JH, Hwang ES, McManus MT, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005; 309(5737):1074-8.
46. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004; 341: 19-39.
47. Gaur T, Lengner CY, Hovhannisym H, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating RUNX2 gene expression. J Biol Chem 2005; 280(39): 33132-40.
48. Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004; 93(6):1210-30.
49. de Boer J, Siddappa R, Gaspar C, van Apeldoomn A, Fodde R, van Blitterswijk C. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 2004; 34(5): 818-26.
50. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005; 8(5): 739-50.
51. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/ beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005; 8(5): 727-38.
52. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999; 13(16): 2072-86.
53. Maeda Y, Nakamura E, Nguyen MT, et al. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci USA 2007; 104(15):6382-7.
54. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004; 131(6): 1309-18.
55. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005; 132(1): 49-60.
56. Pfeilschifter J, Wolf O, Neumann A, Minne HW, Mundy GR, Ziegler R. Chemotactic response of osteoblast like cells to transforming growth factor beta. J Bone Miner Res 1990; 5(8): 825-30.
57. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 1998; 9(7): 1903-18.
58. Bonewald LF, Schwartz Z, Swain LD, Ramirez V, Poser J, Boyan BD. Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cell cultures. J Cell Physiol 1990; 145(2)1200-6.
59. Ducy P. Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000; 57(6): 2207-14.
60. Hughes FJ, Collyer J, Stanfield M, Goodman SA. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995; 136(6): 2671-7.
61. Hay E, Lemonnier J, Fromigue O, Marie PJ. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 2001; 276(31): 29028-36.
62. Celil AB, Hollinger JO, Campbell PG. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem 2005; 95(3): 518-28.
63. Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002; 16(12): 1446-65.
64. Globus RK, Plouet J, Gospodarowicz: D. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 1989; 124(3): 1539-47.
65. Gonzalez AM, Hill DJ, Logan A, Maher PA, Baird A. Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res 1996; 39(3): 375-85.
66. Valta MP, Hentunen T, Qu Q, Valve EM, et al. Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. Endocrinology 2006; 147(5): 2171-82.
67. Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci 2005; 10: 1961-76.
68. Schnabel M, Fichtel I, Gotzeu L, Schlegel J. Differential expression of Notch genes in human osteoblastic cells. Int J Mol Med 2002; 9(3): 229-32.
69. Tezuka K, Yasuda M, Watanabe N, et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 2002; 17(2): 231-9.
70. Aubin JE. Bone stem cells. J Cell Biochem Suppl 1998; 30-31: 73-82.
71. Väänänen HK. Matrix vesicles and calcification of chicken epiphyseal cartilage. Oulu: University of Oulu; 1980.
72. Landis WJ, Song MJ, Leith A, McEwen L, McEwen BF. Minenal and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction. J Struct Biol 1993; 110(1):39-54.
73. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 2005; 10: 822-37.
74. Parfitt AM. Osteonal, hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994; 55(3): 273-86.
75. Miller SC, Bowman BM, Smith JM, Jee WS. Characterization of endosteal bone-lining cells from fatty marrow bone sites in adult beagles. Anat Rec 1980; 198(2): 163-73.
76. Rubinacci A, Villa I, Dondi Benelli F, et al. Osteocyte-bone lining cell system at the origin of steady ionic current in damaged amphibian bone. Calcif Tissue Int 1998; 63(4): 331-9.
77. Chow JW, Wilson AJ, Chambers TJ, Fox SW. Mechanical loading stimulates bone formation by reactivation of bone lining cells in 13-week-old rats. J Bone Miner Res 1998; 13(11): 1760-7.
78. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16(9):1575-82.
79. Trueta J. The role of the vessels in osteogenesis. J Bone Joint Surg Br 1963; 45-B(2): 402-18.
80. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res 1998; (355 Suppl): S82-9.
81. Zelzer E, Olsen BR. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 2005; 65: 169-87.
82. Wang DS, Yamazaki K., Nohtomi K, et al. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996; 11(4):472-9.
83. Wang DS, Miura M, Demura H, Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997; 138(7): 2953-62.
84. Scutt A, Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 1999; 64(1): 69-77.
85. Walsh S, Jefferiss CM, Stewart K, Beresford JN. IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 2003; 33(1): 80-9.
86. Fiedler J, Etzel N, Brenner RE. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 2004; 93(5): 990-8.
87. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36(4): 568-84.
88. Muschler GF, Nakamoto C, Grifffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004; 86-A(7):1541-58.
89. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 2005; 11 (5-6): 787-802.
90. Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000; 49(3): 328-37.
91. Shang Q, Wang Z, Liu W, Shi Y, Cui L, Cao Y. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 2001; 12(6): 586-93; discussion 594-5.
92. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftmen in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79(11):1607-14.
93. Pereira RF, O'Hara MD, Laptev AV, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 1998; 95(3): 1142-7.
94. Ichioka N, Inaba M, Kushida T, et al. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 2002; 20(6): 542-51.
95. Tai G, Polak JM, Bishop AE, Christodoulou I, Buttery LD. Differentiation of osteoblasts from murine embryonic stem cells by over-expression of the transcriptional factor osterix. Tissue Eng 2004; 10(9-10):1456-66.
96. Tu Q, Valverde P, Chen J. Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun 2006; 341(4):1257-65.
97. Kurata H, Guillot PV, Chan J, Fisk NM. Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng 1007; 13(7): 1513-23.
98. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25(11): 2896-902.
99. Hollinger JO, Brekke J, Gruskin E, Iee D. Role of bone substitutes. Clin Orthop Relat Res 1996; (324): 55-65.
100. Betz RR. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 2002; 25(5 Suppl): s561-70.
101. Andrades JA, Santamaria JA, Nimni ME, Becerra J. Selection and amplification of a bone marrow cell population and its induction to the chondro-osteogenic lineage by rhOP-1: an in vitro and in vivo study. Int J Dev Biol 2001; 45(4):689-93.
102. Cinotti G, Patti AM, Vulcano A, et al. Experimental posterolateral spinal fusion with porous ceramics and mesenchymal stem cells. J Bone Joint Surg Br 2004; 86(1): 135-42.
103. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 1998; (355 Suppl): S247-56.
104. Schliephake H, Knebel JW, Aufderheide M, Tauscher M. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep. Int J Oral Maxillofac Surg 2001; 30(6): 531-7.
105. Qiu Q, Ducheyne P, Gao H, Ayyaswamy P. Formation and differentiation of three-dimensional rat marrow stromal cell culture on microcarriers in a rotating-wall vessel. Tissue Eng 1998; 4(1): 19-34.
106. Bancroft GN, Sikavitsas VI, van den Dolder J, et al. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci USA 2002; 99(20): 12600-5.
107. Sikavitsas VI, Bancroft GN, Mikos AG. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 2002; 62(1): 136-48.
108. Nakagawa K, Abukawa H, Shin MY, Terai H, Troulis MJ, Vacanti JP. Osteoclastogenesis on tissue-enginecred bone. Tissue Eng 2004; 10(1-2): 93-100.
109. Parfitt AM. The cellular basis of bone turnover and bone loss: a rebuttal of the osteocytic resorption-bone flow theory. Clin Orthop 1977; (127): 236-47.
110. Palumbo C, Palazzini S, Zaffe D, Marotti G. Osteocyte differentiation in the tibia of newborn rabbit: an ultrastructural study of the formation of cytoplasmic processes. Acta Anat (Basel) 1990a; 137(4): 350-8.
111. Palumbo C, Palazzini S, Marotti G. Morphological study of intercellular junctions during osteocyte differentiation. Bone 1990b; 11(6): 401-6.
112. Nefussi JR, Sautier JM, Nicolas V, Forest N. How osteoblasts become osteocytes: a decreasing matrix forming process. J Biol Buccale 1991; 19(1): 75-82.
113. Pawlicki R. Studies of the fossil dinosaur bone in the scanning electron microscope. Z Mikrosk Anat Forsch 1975; 89(2): 393-8.
114. Schweitzer MH, Wittmeyer JL, Horner JR, Toporski JK. Soft-tissue vessels and cellular preservation in Tyrannosaurus rex. Science 2005; 307(5717): 1952-5.
115. Kamioka H, Honjo T, Takano-Yamamoto T. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone 2001; 28(2): 145-9.
116. Cerri PS, Boabaid F, Katchburian E. Combined TUNEL and TRAP methods suggest that apoptotic bone cells are inside vacuoles of alveolar bone osteoclasts in young rats. J Periodontal Res 2003; 38(2): 223-6.
117. Elmardi AS, Katchburian MV, Katchburian E. Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption. Calcif Tissue Int 1990; 46(4): 239-45.
118. Palumbo C, Ferretti M, Ardizzoni A, Zaffe D, Marotti G. Osteocyte-osteoclast morphological relationships and the putative role of osteocytes in bone remodeling. J Musculoskelet Neuronal Interact 2001; 1(4): 327-32.
119. Suzuki R, Domon T, Wakita M, Akisaka T. The reaction of osteoclasts when releasing osteocytes from osteocytic lacunae in the bone during bone modeling. Tissue Cell 2003; 35(3): 189-97.
120. Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem 2002; 85(1): 185-97.
121. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell.Biol 1991; 115(4): 1091-105.
122. Matikainen T, Väänänen HK. Osteocyte-like cell line MLO-Y4 expresses estrogen receptors alpha and beta. Acta Orthop Scand (Suppl 287) 1999; 70: 9.
123. Braidman IP, Davenport LK, Carter DH, Selby PL, Mawer EB, Freemont AJ. Preliminary in situ identification of estrogen target cells in bone. J Bone Miner Res 1995; 10(1): 74-80.
124. Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 1997; 20(2): 87-92.
125. Vidal O, Kindblom LG, Ohlsson C. Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 1999; 14(6): 923-9.
126. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl 2001; Suppl 36: 144-55.
127. Wang Q, Yu JH, Zhai HH, et al. Temporal expression of estrogen receptor alpha in rat bone marrow mesenchymal stem cells. Biochem Biophys Res Commun 2006; 347(1): 117-23.
128. Leskela HV, Olkku A, Lehtonen S, et al. Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts. Bone 2006; 39(5): 1026-34.
129. Heino TJ, Hentunen TA, Vaananen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res 2004; 294(2): 458-68.
130. Wada Y, Kataoka H, Yokose S, et al. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. Bone 1998; 22(5): 479-85.
131. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78(1): 55-62.
132. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84(12): 4164-73.
133. Rituvala H. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. Embo J 1989; 8(10): 2933-41.
134. Tezuka K, Takeshita S, Hakeda Y, Kumegawa M, Kikuno R, Hashimoto-Gotoh T. Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun 1990; 173(1): 246-51.
135. Gieffers C, Engelhardt W, Brenzel G, Matsuishi T, Frey J. Receptor binding of osteoblast-specific factor 1 (OSF-1/HB-GAM) to human osteosarcoma cells promotes cell attachment. Eur J Cell Biol 1993; 62(2): 352-61.
136. Imai S, Kaksonen M, Raulo E, et al. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol 1998; 143(4): 1113-28.
137. Tare RS, Oreffo RO, Clarke NM, Roach HI. Pleiotrophin/ Osteoblast-stimulating factor 1: dissecting its diverse functions in bone formation. J Bone Miner Res 2002; 17(11): 2009-20.
138. Yang X, Tare RS, Partridge KA, et al. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for time engineering. J Bone Miner Res 2003; 18(1): 47-57.
139. Frost HM. A 2003 update of bone physiology and Wolff's Law for clinicians. Angle Orthod 2004; 74(1): 3-15.
140. You L, Cowin SC, Schaffler MB, Weinbaum S. A model for strain amplification in the actin cytoskeleton of osteocytes due to fluid drag on pericellular matrix. J Biomech 2001; 34(11): 1375-86.
141. Han Y, Cowin SC, Schaffler MB, Weinbaum S. Mechanotransduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci USA 2004; 101(47): 16689-94.
142. Klein-Nulend J, Burger EH, Semeins CM, Raisz LG, Pilbeam CC. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells. J Bone Miner Res 1997; 12(1): 45-51.
143. Westbroek I, Ajubi NE, Alblas MJ, et al. Differential stimulation of prostaglandin G/H synthase-2 osteocytes and other osteogenic cells by pulsating fluid flow. Biochem Biophys Res Commun 2000; 268(2): 414-9.
144. Klein-Nulend J, Semeins CM, Ajubi NE, Nijweide PJ, Burger EH. Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts-correlation with prostaglandin upregulation. Biochem Biophys Res Commun 1995; 217(2): 640-8.
145. Zaman G, Pitsillides AA, Rawlinson SC, et al. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J Bone Miner Res 1999; 14(7): 1123-31.
146. Lean JM, Jagger CJ, Chambers TJ, Chow JW. Increased insulin-like growth factor I mRNA expression in rat osteocytes in response to mechanical stimulation. Am J Physiol 1995; 268(2 Pt 1): E318-27.
147. Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000; 141(7): 2674-82.
148. Sawakami K, Robling AG, Ai M, et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for die anabolic bone response to parathyroid hormone treatment. J Biol Chem 2006; 281(33): 23698-711.
149. Sutherland MK, Geoghegan JC, Yu C, et al. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone 2004; 35(4): 828-35.
150. Robling AG, Bellido T, Turner CH. Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 2006; 6(4): 354.
151. Xing W, Baylink D, Kesavan C, et al. Global gene expression analysis in the bones reveals involvement of several novel genes and pathways in mediating an anabolic response of mechanical loading in mice. J Cell Biochem 2005; 96(5): 1049-60.
152. Belanger LF. Osteocytic osteolysis. Calcif Tissue Res 1969; 4(1): 1-12.
153. Fermor B, Skerry TM. PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res 1995; 10(12): 1935-43.
154. Davideau JL, Papagerakis P, Hotton D, Lezot F, Berdal A. In situ investigation of vitamin D receptor, alkaline phosphatase, and osteocalcin gene expression in oro-facial mineralized tissues. Endocrinology 1996; 137(8): 3577-85.
155. Cullinane DM. The role of osteocytes in bone regulation: mineral homeostasis versus mechanoreception. J Musculoskelet Neuronal Interact 2002; 2(3): 242-4.
156. Miao D, Bai X, Panda D, McKee M, Karaplis A, Goltzman D. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology 2001; 142(2): 926-39.
157. Nampei A, Hashimoto J, Hayashida K, et al. Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in oswocytes in human bone. J Bone Miner Metab 2004; 22(3): 176-84.
158. Rowe PS, Kumagai Y, Gutierrez G, et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004; 34(2): 303-19.
159. Francis F, Strom TM, Hennig S, et al. Genomic organization of the human PEX gene mutated in X-linked dominan hypophosphatemic rickets. Genome Res 1997; 7(6): 573-85.
160. Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblas/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003; 278(3): 1998-2007.
161. Toyosawa S, Shintani S, Fujiwara T, et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 2001; 16(11): 2017-26.
162. Ye L, MacDougall M, Zhang S, et al. Deletion of dentin matrix protein-1 leads to a partial failure of maturation of predentin into dentin, hypomineralization, and expanded cavities of pulp and root canal during postnatal tooth development. J Biol Chem 2004; 279(18): 19141-8.
163. Ye L, Mishina Y, Chen D, et al. Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype. J Biol Chem 2005; 280(7): 6197-203.
164. Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006; 38(11): 1310-5.
165. Lorenz-Depiereux B, Bastepe M, Benet-Pages A, et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006; 38(11): 1248-50.
166. Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soc Nephrol 2007; 18(6): 1637-47.
167. van Bezooijen RL, Roelen BA, Visser A, et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004; 199(6): 805-14.
168. Brunkow ME, Gardner JC, Van Ness J, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001; 68(3): 577-89.
169. Winkler DG, Sutherland MK, Geoghegan JC, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. Embo J 2003; 22(23): 6267-76.
170. van Bezooijen RL, Svensson JP, Eefting D, et al. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res 2007; 22(1): 19-28.
171. Bellido T, Ali AA, Gubrij I, et al. Chronic Elevation of PTH in Mice Reduces Expression of Sclerostin by Osteocytes: a Novel Mechanism for Hormonal Control of Osteoblastogenesis. Endocrinology 2005; 146(11): 4577-83.
172. Keller H, Kneissel M. SOST is a target gene for PTH in bone. Bone 2005; 37(2): 148-58.